Trial Profile
Phase I/II trial of IP1510 in patients with cancer cachexia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 29 Feb 2016
Price :
$35
*
At a glance
- Drugs IP 1510 (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- 29 Feb 2016 Results published in Journal of Cachexia.
- 29 Feb 2016 Interim data will be presented at the 6th Cachexia Conference in Milan December 2011, as per company's website.
- 29 Feb 2016 New trial record